---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-064291"
form_type: "8-K"
ticker: "ORIC"
cik: "0001796280"
company_name: "Oric Pharmaceuticals, Inc."
filed_at: "2026-02-23T23:59:59+00:00"
generated_at: "2026-05-16T01:13:51.598422+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# ORIC files new $200M ATM offering; prior program fully utilized

## Summary
- New prospectus supplement filed Feb 26, 2026 for up to $200M in shares via Jefferies.
- Prior $200M program (2024) terminated after raising $139.7M gross from 13.48M shares.
- No further sales will be made under the 2024 prospectus supplement.
- Legal opinion from Wilson Sonsini filed as Exhibit 5.1.

## SEC filing metadata
- accession: 0001193125-26-064291
- form_type: 8-K
- ticker: ORIC
- cik: 0001796280
- company_name: Oric Pharmaceuticals, Inc.
- filed_at: 2026-02-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1796280/000119312526064291/0001193125-26-064291-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1796280/000119312526064291/d25338d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-064291
- JSON: https://secwatch.observer/filing/0001193125-26-064291.json
- Plain text: https://secwatch.observer/filing/0001193125-26-064291.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.